SEC Form 4 · accession 0001209191-17-033126
QUAKER CHEMICAL CORP · KWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
L Wilbert Platzer
Officer — VP & Managing Dtr - EMEA
Period of report
May 15, 2017
Accepted (ET)
May 17, 2017 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000081362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2017 | M | 710 | $58.26 | A | 7,520 | D | |
| Common StockF1 | May 15, 2017 | S | 710 | $140.4854 | D | 6,810 | D | |
| Common Stock | May 15, 2017 | M | 2,209 | $73.47 | A | 9,019 | D | |
| Common StockF1 | May 15, 2017 | S | 2,209 | $140.4854 | D | 6,810 | D | |
| Common Stock | May 15, 2017 | M | 1,489 | $87.30 | A | 8,299 | D | |
| Common StockF1 | May 15, 2017 | S | 1,489 | $140.4854 | D | 6,810 | D | |
| Common Stock | May 15, 2017 | M | 1,213 | $72.12 | A | 8,023 | D | |
| Common StockF1 | May 15, 2017 | S | 1,213 | $140.4854 | D | 6,810 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $58.26 | May 15, 2017 | M | 710 | D | — | Mar 5, 2020 | Common Stock | 710 | 0 | D |
| Employee Stock Option (right to buy)F3 | $73.47 | May 15, 2017 | M | 2,209 | D | — | Feb 27, 2021 | Common Stock | 2,209 | 0 | D |
| Employee Stock Option (right to buy)F4 | $87.30 | May 15, 2017 | M | 1,489 | D | — | Feb 25, 2022 | Common Stock | 1,489 | 744 | D |
| Employee Stock Option (right to buy)F5 | $72.12 | May 15, 2017 | M | 1,213 | D | — | Feb 23, 2023 | Common Stock | 1,213 | 2,426 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.84, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- F2The options under this grant vested in three annual installments: 710 shares on March 5, 2014; 710 shares on March 5, 2015; and 710 shares on March 5, 2016.
- F3The options for this grant vested in three annual installments: 737 shares on February 27, 2015; 736 shares on February 27, 2016; and 736 shares on February 27, 2017.
- F4The options for this grant vest in three annual installments: 745 shares on February 25, 2016; 744 shares on February 25, 2017; and 744 shares on February 25, 2018.
- F5The options for this grant vest in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019.